As of 2024-12-15, the Relative Valuation of Poolbeg Pharma PLC (POLB.L) is (14.71) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 7.20 GBP, the upside of Poolbeg Pharma PLC based on Relative Valuation is -304.3%.
The range of the Relative Valuation is (14.00) - (13.53) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.8x - 15.8x | 13.5x |
| Forward P/E multiples | 16.3x - 25.3x | 20.8x |
| Fair Price | (14.00) - (13.53) | (14.71) |
| Upside | -294.4% - -288.0% | -304.3% |
| Date | P/E |
| 2024-12-05 | -8.28 |
| 2024-12-04 | -8.28 |
| 2024-12-03 | -8.57 |
| 2024-12-02 | -8.57 |
| 2024-11-29 | -8.57 |
| 2024-11-28 | -8.57 |
| 2024-11-27 | -8.32 |
| 2024-11-26 | -8.45 |
| 2024-11-25 | -8.92 |
| 2024-11-22 | -9.04 |
| 2024-11-21 | -8.86 |
| 2024-11-20 | -8.86 |
| 2024-11-19 | -9.21 |
| 2024-11-18 | -9.44 |
| 2024-11-15 | -9.68 |
| 2024-11-14 | -9.68 |
| 2024-11-13 | -9.39 |
| 2024-11-12 | -9.79 |
| 2024-11-11 | -10.20 |
| 2024-11-08 | -10.28 |
| 2024-11-07 | -10.61 |
| 2024-11-06 | -10.49 |
| 2024-11-05 | -10.55 |
| 2024-11-04 | -10.26 |
| 2024-11-01 | -9.68 |
| 2024-10-31 | -9.33 |
| 2024-10-30 | -9.09 |
| 2024-10-29 | -8.98 |
| 2024-10-28 | -9.21 |
| 2024-10-25 | -9.44 |
| 2024-10-24 | -9.33 |
| 2024-10-23 | -9.21 |
| 2024-10-22 | -9.33 |
| 2024-10-21 | -9.62 |
| 2024-10-18 | -9.68 |
| 2024-10-17 | -9.62 |
| 2024-10-16 | -9.33 |
| 2024-10-15 | -8.86 |
| 2024-10-14 | -8.98 |
| 2024-10-11 | -9.33 |
| 2024-10-10 | -8.63 |
| 2024-10-09 | -9.04 |
| 2024-10-08 | -9.68 |
| 2024-10-07 | -10.08 |
| 2024-10-04 | -10.08 |
| 2024-10-03 | -10.08 |
| 2024-10-02 | -10.61 |
| 2024-10-01 | -11.19 |
| 2024-09-30 | -11.13 |
| 2024-09-27 | -11.19 |